Joyce Pagan

Joyce Pagan

Editor https://www.oncologynurseadvisor.com
Joyce Pagan is the editor of Oncology Nurse Advisor, part of the Haymarket Oncology brands. Prior to taking the helm of Oncology Nurse Advisor, Joyce held many roles in medical publishing brands ranging from design, production, and editorial that served various specialties.

All articles by Joyce Pagan

The FDA approved obinutuzumab (Gazyva) or use in combination with chlorambucil to treat patients with previously untreated CLL, ibrutinib (Imbruvica) received FDA approval for the treatment of mantle cell lymphoma, and other FDA actions.